Malta - English - Medicines Authority

+pharma arzneimittel gmbh hafnerstrasse 211 8054 graz , austria - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Malta - English - Medicines Authority

+pharma arzneimittel gmbh hafnerstrasse 211 8054 graz , austria - film-coated tablet - metformin hydrochloride 1000 mg vildagliptin 50 mg - drugs used in diabetes

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - clostridium botulinum toxin type a -

Canada - English - Health Canada

euro-pharm international canada inc - vitamin d3 - capsule - 5000unit - vitamin d3 5000unit - vitamin d

Canada - English - Health Canada

euro-pharm international canada inc - vitamin d3 - capsule - 10000unit - vitamin d3 10000unit - vitamin d

Canada - English - Health Canada

euro-pharm international canada inc - vitamin d3 - capsule - 50000unit - vitamin d3 50000unit - vitamin d

Canada - English - Health Canada

euro-pharm international canada inc - chlorhexidine gluconate - mouthwash - 0.12% - chlorhexidine gluconate 0.12% - miscellaneous anti-infectives

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite extract, quantity: 10 ir/ml - injection, suspension - excipient ingredients: mannitol; aluminium hydroxide hydrate; sodium hydroxide; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - european house dust mite extract, quantity: 10 ir/ml - injection, suspension - excipient ingredients: mannitol; aluminium hydroxide hydrate; sodium chloride; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells);   - powder for infusion - 40 u/ml - active: imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells)   excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate - cerezyme is indicated for long - term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; b) thrombocytopenia; c) bone disease; d) hepatomegaly or splenomegaly.